Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivorsXinyu Liu, Jingnan Li, Minjiang Chen et al.|EBioMedicine|2024Cited by 40
Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung CancerHongge Liang, Mengzhao Wang, Minjiang Chen et al.|Frontiers in Immunology|2022Cited by 34
[Clinical-radiological-pathological Characteristics of 297 Cases of Surgical Pathology Confirmed Benign Pulmonary Lesions in Which Malignancy Could Not Be Excluded in Preoperative Assessment: A Retrospective Cohort Analysis in a Single Chinese Hospital].Yongjian Liu, Mengzhao Wang, Chao Guo et al.|PubMed|2020Cited by 5